Showing results (91-100 of 955) with videos related to
Sort By:
Pageof 96
International Journal of Radiation Biology|November 29, 2005
Evaluation of cisplatin treatment given concurrently with pulsed irradiation in cisplatin sensitive and resistant human ovarian carcinoma cell linesJ M Leblanc, P RaaphorstStatistics in Medicine|July 15, 2025
Time-Varying Bayesian Network Meta-AnalysisPatrick M LeBlanc, David BanksCanadian Journal of Physiology and Pharmacology|October 27, 1999
Renal and vascular effects of chronic nitric oxide synthase inhibition: involvement of endothelin 1 and angiotensin IIM D'Amours, M Lebel, J H Grose, et al.Clinical and Experimental Hypertension (New York, N.Y. : 1993)|September 1, 1994
Plasma endothelin levels and blood pressure in hemodialysis and in CAPD patients. Effect of subcutaneous erythropoietin replacement therapyM Lebel, J H Grose, I Kingma, et al.Brain, Behavior, and Immunity|March 10, 2012
MyD88 deficiency results in both cognitive and motor impairments in miceJ Drouin-Ouellet, M LeBel, M Filali, et al.Prostaglandins, Leukotrienes, and Essential Fatty Acids|January 1, 1996
Eicosanoid modulation of the norepinephrine effect on blood pressure and renal hemodynamics in humansP Isenring, M Lebel, P Falardeau, et al.Hypertension (Dallas, Tex. : 1979)|June 16, 2001
Captopril suppression versus salt loading in confirming primary aldosteronismM Agharazii, P Douville, J H Grose, et al.Therapeutic Drug Monitoring|January 1, 1986
Protein binding of ceftriaxone: comparison of three techniques of determination and the effect of 2-hydroxybenzoylglycine, a drug-binding inhibitor in uremiaC Fiset, F Vallée, M LeBel, et al.Journal of the American Society of Nephrology : JASN|January 24, 1998
Hemodynamic and hormonal changes during erythropoietin therapy in hemodialysis patientsM Lebel, I Kingma, J H Grose, et al.Antimicrobial Agents and Chemotherapy|July 1, 1985
Difference in blister fluid penetration after single and multiple doses of ceftriaxoneM LeBel, S Grégoire, M Caron, et al.Pageof 96